TY - JOUR
T1 - Structural and folding dynamic properties of the T70N variant of human lysozyme
AU - Esposito, Gennaro
AU - Garcia, Julian
AU - Mangione, Palma
AU - Giorgetti, Sofia
AU - Corazza, Alessandra
AU - Viglino, Paolo
AU - Chiti, Fabrizio
AU - Andreola, Alessia
AU - Dumy, Pascal
AU - Booth, David
AU - Hawkins, Philip N.
AU - Bellotti, Vittorio
PY - 2003/7/11
Y1 - 2003/7/11
N2 - Definition of the transition mechanism from the native globular protein into fibrillar polymer was greatly improved by the biochemical and biophysical studies carried out on the two amyloidogenic variants of human lysozyme, I56T and D67H. Here we report thermodynamic and kinetic data on folding as well as structural features of a naturally occurring variant of human lysozyme, T70N, which is present in the British population at an allele frequency of 5% and, according to clinical and histopathological data, is not amyloidogenic. This variant is less stable than the wild-type protein by 3.7 kcal/mol, but more stable than the pathological, amyloidogenic variants. Unfolding kinetics in guanidine are six times faster than in the wild-type, but three and twenty times slower than in the amyloidogenic variants. Enzyme catalytic parameters, such as maximal velocity and affinity, are reduced in comparison to the wild-type. The solution structure, determined by 1H NMR and modeling calculations, exhibits a more compact arrangement at the interface between the β-sheet domain and the subsequent loop on one side and part of the α domain on the other side, compared with the wild-type protein. This is the opposite of the conformational variation shown by the amyloidogenic variant D67H, but it accounts for the reduced stability and catalytic performance of T70N.
AB - Definition of the transition mechanism from the native globular protein into fibrillar polymer was greatly improved by the biochemical and biophysical studies carried out on the two amyloidogenic variants of human lysozyme, I56T and D67H. Here we report thermodynamic and kinetic data on folding as well as structural features of a naturally occurring variant of human lysozyme, T70N, which is present in the British population at an allele frequency of 5% and, according to clinical and histopathological data, is not amyloidogenic. This variant is less stable than the wild-type protein by 3.7 kcal/mol, but more stable than the pathological, amyloidogenic variants. Unfolding kinetics in guanidine are six times faster than in the wild-type, but three and twenty times slower than in the amyloidogenic variants. Enzyme catalytic parameters, such as maximal velocity and affinity, are reduced in comparison to the wild-type. The solution structure, determined by 1H NMR and modeling calculations, exhibits a more compact arrangement at the interface between the β-sheet domain and the subsequent loop on one side and part of the α domain on the other side, compared with the wild-type protein. This is the opposite of the conformational variation shown by the amyloidogenic variant D67H, but it accounts for the reduced stability and catalytic performance of T70N.
UR - http://www.scopus.com/inward/record.url?scp=0037830693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037830693&partnerID=8YFLogxK
U2 - 10.1074/jbc.M211000200
DO - 10.1074/jbc.M211000200
M3 - Article
C2 - 12709420
AN - SCOPUS:0037830693
SN - 0021-9258
VL - 278
SP - 25910
EP - 25918
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 28
ER -